Spots Global Cancer Trial Database for pel
Every month we try and update this database with for pel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas | NCT02228512 | Large Cell Lymp... Primary Effusio... | Pomalidomide Rituximab Prednisone Etoposide Doxorubicin Vincristine Cyclophosphamid... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma | NCT02911142 | Primary Effusio... B-Cell Neoplasm | Lenalidomide Rituximab Prednisone Etopside Doxorubicin Vincristine Cyclophosphamid... | 18 Years - | National Institutes of Health Clinical Center (CC) |